X
When science and biology combine – the outlook for ADCs in cancer drug development
https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/
haemato-oncology
FDA reapproves Pfizer’s Mylotarg leukaemia drug
FDA gives green light after 7-year absence